Yahoo
NYSE - Delayed Quote USD

Elevance Health, Inc. (ELV)

413.60 -6.47 (-1.54%)
At close: November 2 at 4:00:02 PM EST
413.60 0.00 (0.00%)
After hours: November 2 at 6:48:54 PM EST
Trade ELV on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Ms. Gail Koziara Boudreaux
President, CEO & Director 4.94M -- 1961
Mr. Mark Bradley Kaye
Executive VP & CFO 2.01M -- 1980
Mr. Peter David Haytaian Esq.
Special Advisor 2.06M -- 1970
Mr. Charles Morgan Kendrick Jr.
EVP and President of Commercial & Specialty Health Benefits 1.91M -- 1966
Ms. Felicia Farr Norwood
Executive VP & Chief Health Benefits Officer 2.03M -- 1960
Mr. Scott Wayne Anglin
SVP, Treasurer & Chief Investment Officer -- -- --
Mr. Ronald William Penczek
Senior VP, Controller & Chief Accounting Officer -- -- 1965
Mr. Nathan Allen Rich
Vice President of Investor Relations -- -- --
Ms. Erin M. Wessling
Executive VP & Chief Legal Officer -- -- 1978
Ms. Julie Goon
Senior Vice President of Public Affairs -- -- --

Elevance Health, Inc.

220 Virginia Avenue
Indianapolis, IN 46204
United States
833 401 1577 https://www.elevancehealth.com
Sector: 
Healthcare
Industry: 
Healthcare Plans
Full Time Employees: 
96,129

Description

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Corporate Governance

Elevance Health, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

December 4, 2026 at 12:00 AM UTC

Ex-Dividend Date

December 18, 2026 at 12:00 AM UTC

Dividend Date

January 28, 2027 at 1:30 PM UTC

Elevance Health, Inc. Earnings Date

Recent Events

October 28, 2026 at 12:00 AM UTC

S-3ASR: Offering Registrations

October 21, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 15, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 17, 2026 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

June 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 27, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: